Psychiatric Manifestations in Early to Middle Stages of Fragile X-Associated Tremor-Ataxia Syndrome (FXTAS)

被引:0
作者
Chi, Mei Hung [1 ,2 ]
Bourgeois, James A. [3 ]
Santos, Ellery [1 ,4 ]
Kim, Kyoungmi [1 ,5 ]
Ponzini, Matt Dominic [1 ,5 ]
Mendoza, Guadalupe [6 ]
Schneider, Andrea [1 ,4 ]
Hessl, David [1 ,3 ]
Tassone, Flora [1 ,6 ]
Hagerman, Randi J. [1 ,4 ]
机构
[1] Univ Calif Davis Hlth, Med Invest Neurodev Disorders Inst, Sacramento, CA USA
[2] Natl Cheng Kung Univ Hosp, Dept Psychiat, Tainan, Taiwan
[3] Univ Calif Sacramento, Davis Sch Med, Dept Psychiat & Behav Sci, Sacramento, CA 95819 USA
[4] Univ Calif Sacramento, Davis Sch Med, Dept Pediat, Sacramento, CA USA
[5] Univ Calif Sacramento, Davis Sch Med, Dept Publ Hlth Sci, Sacramento, CA USA
[6] Univ Calif Sacramento, Davis Sch Med, Dept Biochem & Mol Med, Sacramento, CA USA
关键词
TREMOR/ATAXIA SYNDROME FXTAS; MALE CARRIERS; ANXIETY DISORDERS; PREMUTATION; SYMPTOMS; PARKINSONISM; PENETRANCE; DEPRESSION; IMPAIRMENT; PREVALENCE;
D O I
10.1176/appi.neuropsych.20230215
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: The purpose of the present study was to assess the psychiatric manifestations of early to middle stages of fragile X-associated tremor-ataxia syndrome (FXTAS) and their relationship with executive function and FMR1 cytosine-guanine-guanine (CGG) repeat numbers across genders. Methods: Cross-sectional data from 100 participants (62 men, 38 women; mean +/- SD age=67.11 +/- 7.90 years) with FXTAS stage 1, 2, or 3 were analyzed, including demographic information, cognitive measures, psychiatric assessments (Symptom Checklist-90-Revised and Behavioral Dyscontrol Scale-II [BDS-II]), and CGG repeat number. Results: Participants with FXTAS stage 3 exhibited significantly worse psychiatric outcomes compared with participants with either stage 1 or 2, with distinct gender-related differences. Men showed differences in anxiety and hostility between stage 3 and combined stages 1 and 2, whereas women exhibited differences in anxiety, depression, interpersonal sensitivity, obsessive-compulsive symptoms, and somatization, as well as in the Global Severity Index, the Positive Symptom Distress Index, and the Positive Symptom Total. Among male participants, negative correlations were observed between BDS-II total scores and obsessive- compulsive symptoms, as well as between anxiety and CGG repeat number. Conclusions: These findings suggest that even at early FXTAS stages, patients have significant cognitive and other psychiatric symptoms, with notable gender-specific differences. This study underscores the clinical and prognostic relevance of comorbid psychiatric conditions in FXTAS, highlighting the need for early intervention and targeted support for individuals with relatively mild motor deficits.
引用
收藏
页码:20 / 28
页数:9
相关论文
共 35 条
  • [1] Clustering of comorbid conditions among women who carry an FMR1 premutation
    Allen, Emily Graves
    Charen, Krista
    Hipp, Heather S.
    Shubeck, Lisa
    Amin, Ashima
    He, Weiya
    Hunter, Jessica Ezzell
    Sherman, Stephanie L.
    [J]. GENETICS IN MEDICINE, 2020, 22 (04) : 758 - 766
  • [2] Impaired Mitochondrial Function and Dynamics in the Pathogenesis of FXTAS
    Alvarez-Mora, M. I.
    Rodriguez-Revenga, L.
    Madrigal, I.
    Guitart-Mampel, M.
    Garrabou, G.
    Mila, M.
    [J]. MOLECULAR NEUROBIOLOGY, 2017, 54 (09) : 6896 - 6902
  • [3] Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: Newly described fronto-subcortical dementia
    Bacalman, S
    Farzin, F
    Bourgeois, JA
    Cogswell, J
    Goodlin-Jones, BL
    Gane, LW
    Grigsby, J
    Leehey, MA
    Tassone, F
    Hagerman, RJ
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 87 - 94
  • [4] Lifetime Prevalence of Mood and Anxiety Disorders in Fragile X Premutation Carriers
    Bourgeois, James A.
    Seritan, Andreea L.
    Casillas, E. Melina
    Hessl, David
    Schneider, Andrea
    Yang, Ying
    Kaur, Inderjeet
    Cogswell, Jennifer B.
    Nguyen, Danh V.
    Hagerman, Randi J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (02) : 175 - 182
  • [5] Channelopathies in fragile X syndrome
    Deng, Pan-Yue
    Klyachko, Vitaly A.
    [J]. NATURE REVIEWS NEUROSCIENCE, 2021, 22 (05) : 275 - 289
  • [6] Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia
    Famula, Jessica L.
    McKenzie, Forrest
    McLennan, Yingratana A.
    Grigsby, James
    Tassone, Flora
    Hessl, David
    Rivera, Susan M.
    Martinez-Cerdeno, Veronica
    Hagerman, Randi J.
    [J]. FRONTIERS IN NEUROLOGY, 2018, 9
  • [7] A Novel FMR1 PCR Method for the Routine Detection of Low Abundance Expanded Alleles and Full Mutations in Fragile X Syndrome
    Filipovic-Sadic, Stela
    Sah, Sachin
    Chen, Liangjing
    Krosting, Julie
    Sekinger, Edward
    Zhang, Wenting
    Hagerman, Paul J.
    Stenzel, Timothy T.
    Hadd, Andrew G.
    Latham, Gary J.
    Tassone, Flora
    [J]. CLINICAL CHEMISTRY, 2010, 56 (03) : 399 - 408
  • [8] Artificial neural network applied to fragile X-associated tremor/ataxia syndrome stage diagnosis based on peripheral mitochondrial bioenergetics and brain imaging outcomes
    Giulivi, Cecilia
    Wang, Jun Yi
    Hagerman, Randi J.
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [9] Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome
    Grigsby, Jim
    Brega, Angela G.
    Leehey, Maureen A.
    Goodrich, Glenn K.
    Jacquemont, Sebastien
    Loesch, Danuta Z.
    Cogswell, Jennifer B.
    Epstein, Jennifer
    Wilson, Rebecca
    Jardini, Tristan
    Gould, Emma
    Bennett, Rachael E.
    Hessl, David
    Cohen, Susannah
    Cook, Kylee
    Tassone, Flora
    Hagerman, Paul J.
    Hagerman, Randi J.
    [J]. MOVEMENT DISORDERS, 2007, 22 (05) : 645 - 650
  • [10] Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning
    Grigsby, Jim
    Brega, Angela G.
    Bennett, Rachael E.
    Bourgeois, James A.
    Seritan, Andreea L.
    Goodrich, Glenn K.
    Hagerman, Randi J.
    [J]. CLINICAL NEUROPSYCHOLOGIST, 2016, 30 (06) : 944 - 959